Sex-Specific Associations between Gut Microbiome and Non-Alcoholic Fatty Liver Disease among Urban Chinese Adults
暂无分享,去创建一个
J. Long | X. Shu | W. Zheng | H. Cai | Q. Cai | Wanghong Xu | Jiajun Shi | Yaohua Yang | Danxia Yu | C. Flynn | Jie Wu | D. Yu | H. Cai
[1] A. Gasbarrini,et al. Nonalcoholic Fatty Liver Disease (NAFLD) as Model of Gut–Liver Axis Interaction: From Pathophysiology to Potential Target of Treatment for Personalized Therapy , 2021, International journal of molecular sciences.
[2] Stefan Gavriliuc,et al. Long-term storage of feces at −80 °C versus −20 °C is negligible for 16S rRNA amplicon profiling of the equine bacterial microbiome , 2021, PeerJ.
[3] B. Zhong,et al. Compositional alterations of gut microbiota in nonalcoholic fatty liver disease patients: a systematic review and Meta-analysis , 2021, Lipids in health and disease.
[4] J. Long,et al. Long-term diet quality is associated with gut microbiome diversity and composition among urban Chinese adults. , 2021, The American journal of clinical nutrition.
[5] Jian-Min Yuan,et al. Dynamics of hepatic steatosis resolution and changes in gut microbiome with weight loss in nonalcoholic fatty liver disease , 2021, Obesity science & practice.
[6] N. Price,et al. Health and disease markers correlate with gut microbiome composition across thousands of people , 2020, Nature Communications.
[7] Ruimin Chen,et al. Sexual dimorphism of gut microbiota at different pubertal status , 2020, Microbial Cell Factories.
[8] J. Richards,et al. Sex-dependent associations between addiction-related behaviors and the microbiome in outbred rats , 2020, EBioMedicine.
[9] C.-H. Chen,et al. Gut Microbiota Dysbiosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study in Taiwan , 2020, Nutrients.
[10] A. de Gottardi,et al. The gut-liver axis in liver disease: pathophysiological basis for therapy. , 2020, Journal of hepatology.
[11] A. Kurilshikov,et al. Impact of commonly used drugs on the composition and metabolic function of the gut microbiota , 2020, Nature Communications.
[12] A. Zekry,et al. Non-alcoholic fatty liver disease (NAFLD): a review of epidemiology, risk factors, diagnosis and management. , 2019, Internal medicine journal.
[13] Hongliang Li,et al. Unexpected Rapid Increase in the Burden of NAFLD in China From 2008 to 2018: A Systematic Review and Meta‐Analysis , 2019, Hepatology.
[14] H. Tilg,et al. Gut Dysfunction and Non-alcoholic Fatty Liver Disease , 2019, Front. Endocrinol..
[15] J. González‐Gallego,et al. An altered fecal microbiota profile in patients with non-alcoholic fatty liver disease (NAFLD) associated with obesity. , 2019, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.
[16] P. Pérez-Martínez,et al. Sex Differences in the Gut Microbiota as Potential Determinants of Gender Predisposition to Disease , 2019, Molecular nutrition & food research.
[17] R. Knight,et al. A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease , 2019, Nature Communications.
[18] T. Unno,et al. Sex Differences in Gut Microbiota , 2019, The world journal of men's health.
[19] Yeojun Yun,et al. Fecal and blood microbiota profiles and presence of nonalcoholic fatty liver disease in obese versus lean subjects , 2019, PloS one.
[20] Z. Younossi. Non-alcoholic fatty liver disease - A global public health perspective. , 2019, Journal of hepatology.
[21] Austin D. Swafford,et al. Age- and Sex-Dependent Patterns of Gut Microbial Diversity in Human Adults , 2019, mSystems.
[22] P. Gérard,et al. The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD) , 2019, Cellular and Molecular Life Sciences.
[23] J. Tap,et al. Effects of the long-term storage of human fecal microbiota samples collected in RNAlater , 2019, Scientific Reports.
[24] J. Long,et al. Prospective study of oral microbiome and colorectal cancer risk in low‐income and African American populations , 2018, International journal of cancer.
[25] R. Marrie,et al. A comparative study of the gut microbiota in immune-mediated inflammatory diseases—does a common dysbiosis exist? , 2018, Microbiome.
[26] M. Bonder,et al. Analysis of 1135 gut metagenomes identifies sex-specific resistome profiles , 2018, Gut microbes.
[27] A. Gasbarrini,et al. Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease , 2018, Hepatology.
[28] T. Spector,et al. Gut microbiota associations with common diseases and prescription medications in a population-based cohort , 2018, Nature Communications.
[29] Luke R. Thompson,et al. Best practices for analysing microbiomes , 2018, Nature Reviews Microbiology.
[30] E. Comelli,et al. Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance , 2018, Scientific Reports.
[31] Jian-Gao Fan,et al. Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease. , 2017, Hepatobiliary & pancreatic diseases international : HBPD INT.
[32] Shibu Yooseph,et al. Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease. , 2017, Cell metabolism.
[33] M. Laakso,et al. Relationships between gut microbiota, plasma metabolites, and metabolic syndrome traits in the METSIM cohort , 2017, Genome Biology.
[34] P. Paci,et al. Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta‐omics‐based approach , 2017, Hepatology.
[35] Lanjuan Li,et al. Altered Fecal Microbiota Correlates with Liver Biochemistry in Nonobese Patients with Non-alcoholic Fatty Liver Disease , 2016, Scientific Reports.
[36] R. Osawa,et al. Age-related changes in gut microbiota composition from newborn to centenarian: a cross-sectional study , 2016, BMC Microbiology.
[37] J. Raes,et al. Population-level analysis of gut microbiome variation , 2016, Science.
[38] Lawrence A. David,et al. The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota , 2016, Hepatology.
[39] T. Spector,et al. Signatures of early frailty in the gut microbiota , 2016, Genome Medicine.
[40] D. Gevers,et al. The Gut Microbiome Contributes to a Substantial Proportion of the Variation in Blood Lipids , 2015, Circulation Research.
[41] X. Shu,et al. Cohort Profile: The Shanghai Men's Health Study. , 2015, International journal of epidemiology.
[42] Jing Li,et al. Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease , 2015, Scientific Reports.
[43] N. Reo,et al. Altered gut microbial energy and metabolism in children with non-alcoholic fatty liver disease. , 2015, FEMS microbiology ecology.
[44] Angela C. Poole,et al. Human Genetics Shape the Gut Microbiome , 2014, Cell.
[45] H. Yki-Järvinen. Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. , 2014, The lancet. Diabetes & endocrinology.
[46] Jean M. Macklaim,et al. Unifying the analysis of high-throughput sequencing datasets: characterizing RNA-seq, 16S rRNA gene sequencing and selective growth experiments by compositional data analysis , 2014, Microbiome.
[47] Se Jin Song,et al. The treatment-naive microbiome in new-onset Crohn's disease. , 2014, Cell host & microbe.
[48] Masoumeh Sikaroodi,et al. Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[49] Jun Yu,et al. Molecular Characterization of the Fecal Microbiota in Patients with Nonalcoholic Steatohepatitis – A Longitudinal Study , 2013, PloS one.
[50] Lixin Zhu,et al. Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH , 2013, Hepatology.
[51] S. Rabot,et al. Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice , 2012, Gut.
[52] J. Clemente,et al. Human gut microbiome viewed across age and geography , 2012, Nature.
[53] Richard A. Flavell,et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity , 2012, Nature.
[54] Eric P. Nawrocki,et al. An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea , 2011, The ISME Journal.
[55] Baoli Zhu,et al. Characterization of fecal microbial communities in patients with liver cirrhosis , 2011, Hepatology.
[56] William A. Walters,et al. QIIME allows analysis of high-throughput community sequencing data , 2010, Nature Methods.
[57] Martin Hartmann,et al. Introducing mothur: Open-Source, Platform-Independent, Community-Supported Software for Describing and Comparing Microbial Communities , 2009, Applied and Environmental Microbiology.
[58] N. Rothman,et al. The Shanghai Women's Health Study: rationale, study design, and baseline characteristics. , 2005, American journal of epidemiology.
[59] P. Dixon. VEGAN, a package of R functions for community ecology , 2003 .
[60] Bei-fan Zhou. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults--study on optimal cut-off points of body mass index and waist circumference in Chinese adults. , 2002, Biomedical and environmental sciences : BES.
[61] P. O’Toole,et al. COMPOSITIONALDYNAMICS OF THE HUMAN INTESTINALMICROBIOTA WITH AGING : IMPLICATIONS FOR HEALTH , 2022 .
[62] K. Al-Jashamy,et al. Prevalence of colorectal cancer associated with Streptococcus bovis among inflammatory bowel and chronic gastrointestinal tract disease patients. , 2010, Asian Pacific journal of cancer prevention : APJCP.